Literature DB >> 19857633

Nutritional inadequacies in patients with stable heart failure.

Joanne Arcand1, Vanessa Floras, Mavra Ahmed, Abdul Al-Hesayen, Joan Ivanov, Johane P Allard, Gary E Newton.   

Abstract

Sodium restriction is the primary nutritional strategy in heart failure; however, other diet-related concerns may also occur. We characterized dietary intake among stable patients with heart failure and a non-heart-failure cardiac control group to quantify and determine prevalence of inadequate micronutrient intake. Two 3-day food records were completed by 123 patients with heart failure and 58 controls. A subset of each group provided two 24-hour urine collections. Mean intake of sodium (2,540+/-1,122 vs 2,596+/-1,184 mg/day) and potassium (3,190+/-980 vs 3,114+/-828 mg/day) was similar between the heart failure and control groups. Prevalence of inadequate potassium intake was 94% among patients with heart failure and 91% among controls. More than 50% in each group had inadequate intakes of calcium, magnesium, folate, and vitamins D and E. In stable patients with heart failure, sodium intake was not excessive. However, we demonstrated widespread dietary inadequacies of other vitamins and minerals. These findings highlight the importance of diet beyond that of sodium restriction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19857633     DOI: 10.1016/j.jada.2009.08.011

Source DB:  PubMed          Journal:  J Am Diet Assoc        ISSN: 0002-8223


  19 in total

1.  Dietary Vitamin C Deficiency Is Associated With Health-Related Quality of Life and Cardiac Event-free Survival in Adults With Heart Failure.

Authors:  Jia-Rong Wu; Eun Kyeung Song; Debra K Moser; Terry A Lennie
Journal:  J Cardiovasc Nurs       Date:  2019 Jan/Feb       Impact factor: 2.083

Review 2.  Dietary Self-management in Heart Failure: High Tech or High Touch?

Authors:  Eloisa Colin-Ramirez; JoAnne Arcand; Justin A Ezekowitz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-03

Review 3.  Nutrition intervention in heart failure: should consumption of the DASH eating pattern be recommended to improve outcomes?

Authors:  Renad Abu-Sawwa; Sandra B Dunbar; Arshed A Quyyumi; Elisabeth L P Sattler
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

4.  Impact of the DASH diet on endothelial function, exercise capacity, and quality of life in patients with heart failure.

Authors:  Luay Rifai; Carol Pisano; Janel Hayden; Suela Sulo; Marc A Silver
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-04

5.  The association of deficiencies of water-soluble vitamin intake with health-related quality of life and prognosis in patients with heart failure.

Authors:  Kyoung Suk Lee; Debra K Moser; Jae-Hyeong Park; Terry A Lennie
Journal:  Qual Life Res       Date:  2021-01-11       Impact factor: 4.147

Review 6.  What should we tell patients with heart failure about sodium restriction and how should we counsel them?

Authors:  Terry A Lennie; Misook L Chung; Debra K Moser
Journal:  Curr Heart Fail Rep       Date:  2013-09

Review 7.  Micronutrients in chronic heart failure.

Authors:  Selim R Krim; Patrick Campbell; Carl J Lavie; Hector Ventura
Journal:  Curr Heart Fail Rep       Date:  2013-03

8.  Mediterranean and DASH diet scores and mortality in women with heart failure: The Women's Health Initiative.

Authors:  Emily B Levitan; Cora E Lewis; Lesley F Tinker; Charles B Eaton; Ali Ahmed; JoAnn E Manson; Linda G Snetselaar; Lisa W Martin; Maurizio Trevisan; Barbara V Howard; James M Shikany
Journal:  Circ Heart Fail       Date:  2013-10-09       Impact factor: 8.790

9.  Lifestyle Modification with Diet and Exercise in Obese Patients with Heart Failure - A Pilot Study.

Authors:  Allison M Pritchett; Anita Deswal; David Aguilar; John P Foreyt; Wenyaw Chan; Douglas L Mann; Christie Ballantyne; Biykem Bozkurt
Journal:  J Obes Weight Loss Ther       Date:  2012-03-15

10.  Left ventricular assist device effects on metabolic substrates in the failing heart.

Authors:  Lindsay B Weitzel; Amrut V Ambardekar; Andreas Brieke; Joseph C Cleveland; Natalie J Serkova; Paul E Wischmeyer; Brian D Lowes
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.